mRNA and the Future of Biotechnology with Hannu Rajaniemi, Founder and CEO of Helix Nanotechnologies

In this episode, Immad and Raj discuss biotechnology with Hannu Rajaniemi, Founder and CEO of Helix Nanotechnologies. Hannu shares the potential of mRNA as a platform for various applications, including lab-grown meat, cancer treatment, and customized vaccines. Hannu’s broad thinking and ability to tie biotech to social impact make for an engaging conversation that highlights the exciting potential of mRNA technology.

Follow the Curiosity Podcast on:

Instagram: https://www.instagram.com/curiositypod101/ 

TikTok: https://www.tiktok.com/@curiosity_podcast101?is_from_webapp=1&sender_device=pc 

YouTube: https://www.youtube.com/@CuriosityPodcast 

Substack: https://curiositypodcast.substack.com/

Timestamps:

00:02:02 Intro

00:08:52 Nanorobotics and future possibilities

00:11:05 Modeling Biological functions

00:16:04 AI design for immunotherapy

00:22:02 Protein synthesis process

00:26:29 Turning cells into protein factories

00:30:00 mRNA modifications and antiviral sensors

00:32:24 mRNA manufacturing and IP disputes

00:36:26 Liquid biopsies for early cancer detection

00:40:24 Using mRNA for cultured meat

00:45:09 Protein structure prediction

00:49:05 Evolution of SARS-CoV-2

00:52:19 The deadliness of viruses

00:55:55 mRNA wearable and global immune system

01:02:26 Storing information through viruses

01:04:07 Exponential technology and genetics